Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
Hosted on MSN
Acumen targets ALTITUDE-AD Phase 2 topline results in late 2026 while advancing subcutaneous Sabirnetug development
CEO Dan O'Connell reported that Acumen completed enrollment of its 542-participant Phase 2 ALTITUDE-AD study evaluating Sabirnetug for early Alzheimer’s disease, stating, "We completed enrollment of ...
BOULDER, Colo., Dec. 11, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
Three years after development broke ground, people are calling Avila Ranch home. "It's been a great community to live in," said Rose Russo, a resident of Avila Ranch. She and her husband, Chris, moved ...
MELBOURNE, Australia and NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
A contractor says three new retail buildings are next at the Gateway at Buckland development in South Windsor.
The new Pack Edge headquarters, at 955 Portland Road in Saco, consolidates the company’s three facilities in Portland, South Portland and Cumberland. The site also has 75,000 square feet of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results